Active	Status	Sponsor type	Region	Phase	Filter
4 Active 16 Inactive 20 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ma, Hong
TQB2102-Ib/II-01, NCT06431490: A Study of TQB2102 for Injection in the Treatment of HER2-positive Biliary Tract Cancer	Recruiting	1/2	103	RoW	TQB2102 for injection	Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.	Biliary Tract Cancer	05/25	12/25
NCT04519359: Biomarkers Guided Stopping NAs Treatment	Recruiting	N/A	195	RoW	Stop NAs therapy	Nanfang Hospital of Southern Medical University	Chronic Hepatitis b	06/23	06/23
NCT05991531: Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients	Not yet recruiting	N/A	100	RoW		Beijing Friendship Hospital	Chronic Hepatitis B Patients	08/24	08/25
Tan, Wen-fei
ESPOD-BI, NCT04303325: Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation	Recruiting	4	72	RoW	Esketamine, Saline Solution	China Medical University, China	Depression	10/24	12/24